2019 AACA Annual Meeting

June 11-15, 2019 | USA

The American Association of Clinical Anatomists is the international home for the advancement of clinical anatomy knowledge and anatomical services through education, research and scholarship.

Spotlight

Scientific interest in rare disease drug discovery has been growing exponentially and the number of new therapies targeting rare and orphan diseases has doubled in the past 6 years. In this white paper, we have reviewed innovative approaches to develop successful therapies for rare diseases such as gene replacement therapies, antisense oligos, and monoclonal antibodies. We also highlight some of the new classes of therapies including the epigenome and microbiome.


OTHER PAST CONFERENCES

Pharmaceutics And Novel Drug Delivery Systems

June 13-14, 2022 | Italy

The pharmaceutical sector plays a central role in the development and design of drugs and vaccines. Pharma innovation advanced at an astounding rate in the last year to combat the COVID-19 pandemic.

1st Annual Psychedelic Therapeutics and Drug Development Conference

May 23-24, 2022 | USA

1st Annual Psychedelic Therapeutics and Drug Development Conference in 2021, we're thrilled to be hosting the 2nd Annual event on May 23-24, 2022 in Washington, DC.

International Conference and Expo on Toxicology and Applied Pharmacology

June 13-14, 2022 | Italy

Magnus Group extends immense pleasure and honour to invite you to its “International Conference and Expo on Toxicology and Applied Pharmacology" scheduled during June 13-14, 2022 in Rome, Italy.

Pharmaceutical Sciences and Innovations in Pharma Industry

May 23-24, 2022 | Austria

The most anticipated Pharma event in the world and you're invited to attend 22nd World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Scheduled during May 23-24, 2022 Vienna, Austria which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Spotlight

Scientific interest in rare disease drug discovery has been growing exponentially and the number of new therapies targeting rare and orphan diseases has doubled in the past 6 years. In this white paper, we have reviewed innovative approaches to develop successful therapies for rare diseases such as gene replacement therapies, antisense oligos, and monoclonal antibodies. We also highlight some of the new classes of therapies including the epigenome and microbiome.

resources